Stoliarova L G, Kadykov A S, Shvedkov V V, Pivovarova V M
Zh Nevropatol Psikhiatr Im S S Korsakova. 1986;86(2):219-22.
The dopamine agonist parlodel was given to 42 patients with parkinsonism for several months. The drug proved effective in more than one-third of the patients. Different side-effects were observed in almost half of the patients. Parlodel may be used alone in mild cases but generally it is used as an adjunct to L-DOPA therapy. The optimum dose of parlodel is individual and varies within a wide range.